IDEXX Laboratories, Inc. (IDXX) Q2 2008 Earnings Results

IDEXX Laboratories Beats on EPS, Stock Down 7.1%

IDEXX Laboratories reported a positive surprise in EPS, indicating better-than-expected profitability. However, the stock fell by 7.1% in reaction to broader market concerns and management's cautious tone. Investors may be worried about potential challenges ahead, despite the earnings beat.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.63	N/A	+13.11%

Management

Management commentary

Tone: Defensive

Overall, management expressed caution regarding future market conditions. They acknowledged the need for continued focus on cost management.

Management highlighted ongoing challenges in the market.

They emphasized their commitment to maintaining operational efficiency.

IDEXX Laboratories Beats on EPS, Stock Down 7.1%

Key numbers

Management commentary

IDEXX Laboratories, Inc.

More earnings this week

IDEXX Laboratories Beats on EPS, Stock Down 7.1%

Key numbers

Management commentary